Cetera Investment Advisers trimmed its position in Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) by 5.4% during the second quarter, according to the company in its most recent 13F filing with ...
Results that may be inaccessible to you are currently showing.